Image is an illustration, may not reflect the exact product sold.


Other products by LKT Laboratories

LKT Laboratories - A5225-0.5 MG - Endogenous NPR-A agonist. It increases cGMP levels and induces diuresis, natriuresis, and vasodilation. It may inhibit growth of cancer cells.

  • MFR SKU: A5225-0.5 MG
  • ITEM #: 13001380
  • 0 Reviews / 0 Questions
$548.04
Stock Status: SHIPS SOON(reserve your unit today)

ITEM #: 13001380
Atrial natriuretic peptide (ANP) is a cardiomodulatory peptide that binds the natriuretic peptide receptor type A (NPR-A), increasing levels of cGMP and activating cGMP-dependent kinases. ANP e x hibits vasodilatory/hypotensive, diuretic, and natriuretic activities, increasing perfusion and decreasing blood pressure in several models. ANP may also e x hibit anticancer benefit, targeting the Ras-MEK-ERK signaling pathway.
Endogenous NPR-A agonist. It increases cGMP levels and induces diuresis,...
ITEM #: 13001380
Atrial natriuretic peptide (ANP) is a cardiomodulatory peptide that binds the natriuretic peptide receptor type A (NPR-A), increasing levels of cGMP and activating cGMP-dependent kinases. ANP e x hibits vasodilatory/hypotensive, diuretic, and natriuretic activities, increasing perfusion and decreasing blood pressure in several models. ANP may also e x hibit anticancer benefit, targeting the Ras-MEK-ERK signaling pathway.
Endogenous NPR-A agonist. It increases cGMP levels and induces diuresis, natriuresis, and vasodilation. It may inhibit growth of cancer cells.
This listing is for Each
Read More >>

LKT Laboratories - A5225-0.5 MG - Endogenous NPR-A agonist. It increases cGMP levels and induces diuresis, natriuresis, and vasodilation. It may inhibit growth of cancer cells.

  • Item #: 13001380
  • MFR SKU: A5225-0.5 MG

There are no questions about this product yet. Be the first to ask a question.

0 out of 5 stars
5 Star
0 %
4 Star
0 %
3 Star
0 %
2 Star
0 %
1 Star
0 %

Review this product

Tell us about your personal experience

Recently Viewed Items